Department of Endocrinology and Metabolism, National Clinical Research Center for Metabolic Disease, Hunan Provincial Key Laboratory of Metabolic Bone Diseases, The Second Xiang-Ya Hospital, Central South University, Changsha, China.
Department of Radiology, The Second Xiang-Ya Hospital, Central South University, Changsha, China.
Front Endocrinol (Lausanne). 2020 Feb 28;11:77. doi: 10.3389/fendo.2020.00077. eCollection 2020.
Substance P (SP) is a neuropeptide that is released from sensory nerve endings and is widely present in nerve fibers. It acts on bones and related tissues by binding to receptors, thereby regulating bone metabolism, cartilage metabolism, and fracture healing. SP has attracted widespread attention as a signaling substance that can be recognized by both the immune system and the nervous system. Previous studies have shown that bone and chondrocytes can synthesize and secrete sensory neuropeptides and express their receptors, and can promote proliferation, differentiation, apoptosis, matrix synthesis, and the degradation of target cells through autocrine/paracrine modes. In this paper, we review the research progress made in this field in recent years in order to provide a reference for further understanding the regulatory mechanism of bone and cartilage physiology and pathological metabolism.
P 物质(SP)是一种从感觉神经末梢释放出来的神经肽,广泛存在于神经纤维中。它通过与受体结合作用于骨骼和相关组织,从而调节骨代谢、软骨代谢和骨折愈合。SP 作为一种信号物质,可以被免疫系统和神经系统识别,引起了广泛关注。先前的研究表明,骨和软骨细胞可以合成和分泌感觉神经肽,并表达其受体,通过自分泌/旁分泌方式促进靶细胞的增殖、分化、凋亡、基质合成和降解。本文综述了近年来该领域的研究进展,以期为进一步了解骨骼和软骨生理及病理代谢的调节机制提供参考。